1057 related articles for article (PubMed ID: 27655589)
1. Reproductive factors, menopausal hormone therapies and primary liver cancer risk: a systematic review and dose-response meta-analysis of observational studies.
Zhong GC; Liu Y; Chen N; Hao FB; Wang K; Cheng JH; Gong JP; Ding X
Hum Reprod Update; 2016 Dec; 23(1):126-138. PubMed ID: 27655589
[TBL] [Abstract][Full Text] [Related]
2. Incidence of thyroid cancer in women in relation to reproductive and hormonal factors.
McTiernan AM; Weiss NS; Daling JR
Am J Epidemiol; 1984 Sep; 120(3):423-35. PubMed ID: 6475918
[TBL] [Abstract][Full Text] [Related]
3. Is breast cancer risk the same for all progestogens?
Stute P
Arch Gynecol Obstet; 2014 Aug; 290(2):207-9. PubMed ID: 24838289
[TBL] [Abstract][Full Text] [Related]
4. Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies.
Ma H; Bernstein L; Pike MC; Ursin G
Breast Cancer Res; 2006; 8(4):R43. PubMed ID: 16859501
[TBL] [Abstract][Full Text] [Related]
5. Reproductive factors and menopausal hormone therapy and bladder cancer risk in the NIH-AARP Diet and Health Study.
Daugherty SE; Lacey JV; Pfeiffer RM; Park Y; Hoover RN; Silverman DT
Int J Cancer; 2013 Jul; 133(2):462-72. PubMed ID: 23319449
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for epithelial ovarian tumours of borderline malignancy.
Parazzini F; Restelli C; La Vecchia C; Negri E; Chiari S; Maggi R; Mangioni C
Int J Epidemiol; 1991 Dec; 20(4):871-7. PubMed ID: 1800425
[TBL] [Abstract][Full Text] [Related]
7. Reproductive factors and risk of Parkinson's disease in women: A meta-analysis of observational studies.
Lv M; Zhang Y; Chen GC; Li G; Rui Y; Qin L; Wan Z
Behav Brain Res; 2017 Sep; 335():103-110. PubMed ID: 28743601
[TBL] [Abstract][Full Text] [Related]
8. Parity, early menopause and the incidence of bladder cancer in women: a case-control study and meta-analysis.
Dietrich K; Demidenko E; Schned A; Zens MS; Heaney J; Karagas MR
Eur J Cancer; 2011 Mar; 47(4):592-9. PubMed ID: 21067913
[TBL] [Abstract][Full Text] [Related]
9. Menopausal hormone therapy and women's health: An umbrella review.
Zhang GQ; Chen JL; Luo Y; Mathur MB; Anagnostis P; Nurmatov U; Talibov M; Zhang J; Hawrylowicz CM; Lumsden MA; Critchley H; Sheikh A; Lundbäck B; Lässer C; Kankaanranta H; Lee SH; Nwaru BI
PLoS Med; 2021 Aug; 18(8):e1003731. PubMed ID: 34339416
[TBL] [Abstract][Full Text] [Related]
10. Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program.
Ellingjord-Dale M; Vos L; Tretli S; Hofvind S; Dos-Santos-Silva I; Ursin G
Breast Cancer Res; 2017 Jan; 19(1):10. PubMed ID: 28114999
[TBL] [Abstract][Full Text] [Related]
11. Use of postmenopausal hormone therapies and risk of histology- and hormone receptor-defined breast cancer: results from a 15-year prospective analysis of NIH-AARP cohort.
Wang SM; Pfeiffer RM; Gierach GL; Falk RT
Breast Cancer Res; 2020 Nov; 22(1):129. PubMed ID: 33239054
[TBL] [Abstract][Full Text] [Related]
12. Current use of oral contraceptives and the risk of first-ever ischemic stroke: A meta-analysis of observational studies.
Xu Z; Li Y; Tang S; Huang X; Chen T
Thromb Res; 2015 Jul; 136(1):52-60. PubMed ID: 25936231
[TBL] [Abstract][Full Text] [Related]
13. Menopausal hormone therapy and risk of melanoma: Do estrogens and progestins have a different role?
Botteri E; Støer NC; Sakshaug S; Graff-Iversen S; Vangen S; Hofvind S; Ursin G; Weiderpass E
Int J Cancer; 2017 Nov; 141(9):1763-1770. PubMed ID: 28685818
[TBL] [Abstract][Full Text] [Related]
14. Female hormone utilisation and risk of hepatocellular carcinoma.
Tavani A; Negri E; Parazzini F; Franceschi S; La Vecchia C
Br J Cancer; 1993 Mar; 67(3):635-7. PubMed ID: 8382515
[TBL] [Abstract][Full Text] [Related]
15. Reproductive factors, hormone use, and incidence of melanoma in a cohort of US Radiologic Technologists.
Mai JZ; Zhang R; Sargen MR; Little MP; Alexander BH; Tucker MA; Kitahara CM; Cahoon EK
Hum Reprod; 2022 May; 37(5):1059-1068. PubMed ID: 35174864
[TBL] [Abstract][Full Text] [Related]
16. Oral contraceptives, menopausal hormone therapy use and risk of B-cell non-Hodgkin lymphoma in the California Teachers Study.
Lu Y; Wang SS; Sullivan-Halley J; Chang ET; Clarke CA; Henderson KD; Ma H; Duan L; Lacey JV; Deapen D; Bernstein L
Int J Cancer; 2011 Aug; 129(4):974-82. PubMed ID: 20957632
[TBL] [Abstract][Full Text] [Related]
17. Female Estrogen-Related Factors and Incidence of Basal Cell Carcinoma in a Nationwide US Cohort.
Cahoon EK; Kitahara CM; Ntowe E; Bowen EM; Doody MM; Alexander BH; Lee T; Little MP; Linet MS; Freedman DM
J Clin Oncol; 2015 Dec; 33(34):4058-65. PubMed ID: 26527779
[TBL] [Abstract][Full Text] [Related]
18. Association of hormonal and reproductive factors with differentiated thyroid cancer risk in women: a pooled prospective cohort analysis.
O'Grady TJ; Rinaldi S; Michels KA; Adami HO; Buring JE; Chen Y; Clendenen TV; D'Aloisio A; DeHart JC; Franceschi S; Freedman ND; Gierach GL; Giles GG; Lacey JV; Lee IM; Liao LM; Linet MS; McCullough ML; Patel AV; Prizment A; Robien K; Sandler DP; Stolzenberg-Solomon R; Weiderpass E; White E; Wolk A; Zheng W; Berrington de Gonzalez A; Kitahara CM
Int J Epidemiol; 2024 Feb; 53(1):. PubMed ID: 38110618
[TBL] [Abstract][Full Text] [Related]
19. Menopausal hormone therapy and cancer risk: An overestimated risk?
Simin J; Tamimi R; Lagergren J; Adami HO; Brusselaers N
Eur J Cancer; 2017 Oct; 84():60-68. PubMed ID: 28783542
[TBL] [Abstract][Full Text] [Related]
20. Reproductive and menopausal factors and risk of systemic lupus erythematosus in women.
Costenbader KH; Feskanich D; Stampfer MJ; Karlson EW
Arthritis Rheum; 2007 Apr; 56(4):1251-62. PubMed ID: 17393454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
